[Reaction of cells cultured in vitro to sanguinarine and chelerythrin].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to L Novák.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The first pharmacokinetic data are reported of azlocillin injected intramuscularly to adult probands. The blood serum and urinary levels of azlocillin were determined microbiologically in 8 healthy volunteers after intramuscular injection of 2 grams. Peak serum levels of azlocillin were found by the end of hour 1 after injection, average level was (55.06 +/- 10.25) mg/l. At hour 2 the average level was (33.64 +/- 6.46) mg/l. and at hour 4, (9.47 +/- 1.79) mg/l. The biological half-life was 1.4 hour. In urine, (41.2 +/- 7.7)% of the administered dose was eliminated within 8 hours on average.
Hypoxia is one of the commonest causes of perinatal morbidity and mortality. The worst affected are tissues with high oxygen consumption, in particular nervous tissue (Trojan 1978). Criteria enabling prompt and reliable evaluation of the length and intensity of hypoxia are therefore being sought (Saugstad 1975a,b, Tuchschmidt et al .1981, O'Connor et al. 1981a,b). In recent years, conflicting information has appeared in the literature on the possibilities of utilizing the hypoxanthine and xanthine level in body fluids as an indicator of oxygen deficiency (Saugstad 1975a, Tuchschmidt et al. 1981). We therefore tested this criterion in newborn infants at risk from intrauterine hypoxia.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.